Skip to content
Search

Latest Stories

PDA: Current NHS pharmacy services unlikely to permit pharmacy technicians to operate under PGDs

PDA: Current NHS pharmacy services unlikely to permit pharmacy technicians to operate under PGDs
The Pharmacists' Defence Association (PDA) has issued an advisory notice to its members  regarding the latest amendments made to the Human Medicines Regulations made effective starting 26 June 2024

According to the legislative changes,  pharmacy technicians (PTs) can now supply and administer medicines under Patient Group Directions (PGDs) in England, Scotland, and Wales, however  Pharmacists' Defence Association (PDA) says it is only in theory.

The defence association has said that practical implementation requires additional steps which under the current service directions and specifications for community pharmacy NHS commissioned services "will likely not permit PTs to work under them".


It will therefore "be premature to offer specific operational advice to pharmacists involved in the delivery of current community pharmacy NHS commissioned services, involving PGDs" as these are subject to negotiation and necessitate amendments.

PDA has informed its members that these changes should be expected from the respective country pharmacy negotiating bodies in due course.

Advising its members that current NHS commissioned services involving PGDs stipulate that only pharmacists can deliver these services, the association has reiterated key principles regarding PGDs.

A PGD is a legal mechanism allowing the supply of certain prescription-only medicines (POMs) without a prescription.

The PDA highlighted two crucial components of safe medicines supply identified during the Department of Health and Social Care (DHSC) consultation on supervision in community pharmacy:

  1. Preparation, Assembly, Sale, and Supply of Medicines: These activities, which include an accuracy check, can be undertaken by registered pharmacy technicians.
  2. Clinical Assessment: This task is reserved solely for pharmacists due to their comprehensive training and qualifications.

The PDA underscored that PGDs typically require "a clinical assessment" to establish a diagnosis, ensure the correct PGD is chosen, and address "potential interactions with complex polypharmacy regimes or co-morbidities".

Unlike the dispensing process, PGDs cannot be segmented into smaller tasks.

They are designed to be delivered as a single episode of care by one person.

"Consequently, when the patient safety consideration logic on medicines supply carries through to PGDs it dictates that only pharmacists should be delivering any PGD that involves an element of clinical assessment," the notice stated.

Moreover, these changes do not apply to Northern Ireland, where pharmacy technicians are not regulated.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less